Nanotop (Human Serum Albumin)

Human Serum Albumin functions as a natural plasma protein that binds water and small solutes, creating oncotic pressure within the vascular compartment. This pressure draws fluid from the interstitial space back into the bloodstream, expanding plasma volume and improving hemodynamic stability in conditions where albumin is deficient.

The dose of Nanotop is individualized. A qualified prescriber determines the amount and frequency based on the patient’s serum albumin level, body weight, clinical condition, and response to therapy. No fixed regimen is provided in public information.

Human Serum Albumin is classified with an unknown pregnancy category. Use during pregnancy or lactation should be based on a careful risk‑benefit assessment by the treating physician, considering the severity of the maternal condition and the availability of alternative therapies.

To order Nanotop, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.

Nanotop provides Human Serum Albumin of EU origin, meeting stringent quality standards. Compared with synthetic colloids, it offers a physiological protein with lower risk of coagulopathy and renal dysfunction. Relative to other albumin brands, its clinical profile is similar; differences may lie in manufacturing source, packaging, and supply chain reliability.

Nanotop should be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking. If the product reaches room temperature, it may be used within a limited time as indicated on the label, but should be returned to refrigeration promptly.

Nanotop is administered by subcutaneous injection using aseptic technique. The healthcare professional selects an appropriate injection site, prepares the dose according to the prescriber’s instructions, and injects the solution slowly to minimize discomfort. Monitoring of vital signs and fluid balance is recommended after administration.

The most serious adverse reactions include anaphylactic or severe allergic responses, volume overload that can lead to pulmonary edema, and thromboembolic events. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.

Nanotop is contraindicated in individuals with known hypersensitivity to Human Serum Albumin or any excipients in the formulation. It should also be avoided in patients with uncontrolled heart failure, severe renal impairment, or active pulmonary edema where additional volume could worsen the condition.